On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6% in the morning session after BofA Securities maintained its ...

New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.

Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...

New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...

According to a filing with the Securities and Exchange Commission dated October 8, 2025, Lancaster Investment Management ...

We recently compiled a list of the Cathie Wood's Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other ...

SPT Labtech, and 10x Genomics, Inc. (Nasdaq: TXG), announced a strategic partnership to provide automated workflows for ...

On October 20, 2025, Anthropic and 10x Genomics announced a collaboration to integrate 10x's single cell and spatial biology data analysis tools into Claude for Life Sciences, making these ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...